2,118
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Histopathological evaluation of prostate specimens after thermal ablation may be confounded by the presence of thermally-fixed cells

ORCID Icon, , ORCID Icon, , , , , , & show all
Pages 914-924 | Received 31 May 2019, Accepted 01 Aug 2019, Published online: 29 Aug 2019

References

  • Bill-Axelson A, Holmberg L, Garmo H, et al. Radical prostatectomy or watchful waiting in early prostate cancer. New Eng J Med. 2014;370:932–942.
  • Wilt TJ, Jones KM, Barry MJ, et al. Follow-up of prostatectomy versus observation for early prostate cancer. N Engl J Med. 2017;377:132–142.
  • Hamdy FC, Donovan JL, Lane JA, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375:1415–1424.
  • Donovan JL, Hamdy FC, Lane JA, et al. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2016;375:1425–1437.
  • Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358:1250–1261.
  • van der Poel MG, Henk G, van den Bergh RCN, Briers E, et al. Focal therapy in primary localised prostate cancer: the European Association of Urology position in 2018. Eur Urol. 2018;74:84–91.
  • Valerio M, Cerantola Y, Eggener SE, et al. New and established technology in focal ablation of the prostate: a systematic review. Eur Urol. 2017;71:17–34.
  • Woodrum DA, Gorny KR, Mynderse LA. Mr-guided Prostate Interventions. Top Magn Reson Imaging. 2018;27:141–151.
  • Ahmed HU, Bosaily AE, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389:815–822.
  • Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018;378:1767–1777.
  • Ramsay E, Mougenot C, Staruch R, et al. Evaluation of focal ablation of magnetic resonance imaging defined prostate cancer using magnetic resonance imaging controlled transurethral ultrasound therapy with prostatectomy as the reference standard. J Urol. 2017;197:255–261.
  • Chopra R, Colquhoun A, Burtnyk M, et al. MR imaging–controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: Initial feasibility in humans. Radiology. 2012;265:303–313.
  • Chin JL, Billia M, Relle J, et al. Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: a prospective phase 1 clinical trial. Eur Urol. 2016;70:447–455.
  • Ross AB, Diederich CJ, Nau WH, et al. Highly directional transurethral ultrasound applicators with rotational control for MRI-guided prostatic thermal therapy. Phys Med Biol. 2004;49:189.
  • Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14:199–208.
  • Van Leenders G, Beerlage HP, Ruijter ET, et al. Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate. J Clin Pathol. 2000;53:391–394.
  • Boyes A, Tang K, Yaffe M, et al. Prostate tissue analysis immediately following magnetic resonance imaging guided transurethral ultrasound thermal therapy. J Urol. 2007;178:1080–1085.
  • Burtnyk M, Hill T, Cadieux-Pitre H, et al. Magnetic resonance image guided transurethral ultrasound prostate ablation: a preclinical safety and feasibility study with 28-day followup. J Urol. 2015;193:1669–1675.
  • Ishihara Y, Calderon A, Watanabe H, et al. A precise and fast temperature mapping using water proton chemical shift. Magn Reson Med. 1995;34:814–823.
  • Ramsay E, Mougenot C, Köhler M, et al. MR thermometry in the human prostate gland at 3.0 T for transurethral ultrasound therapy. J Magn Reson Imaging. 2013;38:1564–1571.
  • Siddiqui K, Chopra R, Vedula S, et al. MRI-guided transurethral ultrasound therapy of the prostate gland using real-time thermal mapping: initial studies. Urology. 2010;76:1506–1511.
  • Chopra R, Tang K, Burtnyk M, et al. Analysis of the spatial and temporal accuracy of heating in the prostate gland using transurethral ultrasound therapy and active MR temperature feedback. Phys Med Biol. 2009;54:2615.
  • Böni RA, Sulser T, Jochum W, et al. Laser ablation-induced changes in the prostate: findings at endorectal MR imaging with histologic correlation. Radiology. 1997;202:232–236.
  • Rouvière O, Lyonnet D, Raudrant A, et al. MRI appearance of prostate following transrectal HIFU ablation of localized cancer. Eur Urol. 2001;40:265–274.
  • Bomers JGR, Cornel EB, Futterer JJ, et al. MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imaging. World J Urol. 2017;35:703–711.
  • Rosset R, Bratan F, Crouzet S, et al. Can pre-and postoperative magnetic resonance imaging predict recurrence-free survival after whole-gland high-intensity focused ablation for prostate cancer? Eur Radiol. 2017;27:1768–1775.
  • Biermann K, Montironi R, Lopez-Beltran A, et al. Histopathological findings after treatment of prostate cancer using high‐intensity focused ultrasound (HIFU). Prostate. 2010;70:1196–1200.
  • Germer C, Isbert CM, Albrecht D, et al. Laser-induced thermotherapy for the treatment of liver metastasis. Surg Endoscopy. 1998;12:1317–1325.
  • Bhowmick S, Coad JE, Swanlund DJ, et al. In vitro thermal therapy of AT-1 Dunning prostate tumours. Int J Hyperthermia. 2004;20:73–92.
  • Hennings L, Kaufmann Y, Griffin R, et al. Dead or alive? Autofluorescence distinguishes heat-fixed from viable cells. Int J Hyperthermia. 2009;25:355–363.
  • Stafford RJ, Shetty A, Elliott AM, et al. Magnetic resonance guided, focal laser induced interstitial thermal therapy in a canine prostate model. J Urol. 2010;184:1514–1520.
  • Coad JE, Kosari K, Humar A, et al. Radiofrequency ablation causes ‘thermal fixation’ of hepatocellular carcinoma: a post‐liver transplant histopathologic study. Clin Transplant. 2003;17:377–384.
  • Coad JE. Thermal fixation: a central outcome of hyperthermic therapies. Proceedings of Thermal Treatment of Tissue: Energy Delivery and Assessment III. International Society for Optics and Photonics. 2005. Vol. 5698. p. 15–22.
  • He X, McGee S, Coad JE, et al. Investigation of the thermal and tissue injury behaviour in microwave thermal therapy using a porcine kidney model. Int J Hyperthermia. 2004;20:567–593.
  • Courivaud F, Kazaryan AM, Lund A, et al. Thermal fixation of swine liver tissue after magnetic resonance-guided high-intensity focused ultrasound ablation. Ultrasound Med Biol. 2014;40:1564–1577.
  • Lindner U, Lawrentschuk N, Weersink RA, et al. Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy. Eur Urol. 2010;57:1111–1114.
  • Wu F, Wang Z, Cao Y, et al. Heat fixation of cancer cells ablated with high-intensity-focused ultrasound in patients with breast cancer. Am J Surg. 2006;192:179–184.
  • Künzli B, Abitabile MP, Maurer CA. Radiofrequency ablation of liver tumors: actual limitations and potential solutions in the future. WJH. 2011;3:8–14.
  • Leslie TA, Kennedy JE, Illing RO, et al. High-intensity focused ultrasound ablation of liver tumours: can radiological assessment predict the histological response? BJR. 2008;81:564–571.
  • van Vulpen M, Raaymakers BW, de Leeuw AA, et al. Prostate perfusion in patients with locally advanced prostate carcinoma treated with different hyperthermia techniques. J Urol. 2002;168:1597–1602.
  • Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol• Biol•Phys. 1984;10:787–800.
  • Dewhirst MW, Viglianti BL, Lora-Michiels M, et al. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia. 2003;19:267–294.
  • Damianou C, Hynynen K. The effect of various physical parameters on the size and shape of necrosed tissue volume during ultrasound surgery. J Acoust Soc Am. 1994;95:1641–1649.
  • Fan X, Hynynen K. Ultrasound surgery using multiple sonications—treatment time considerations. Ultrasound Med Biol. 1996;22:471–482.
  • Yarmolenko PS, Moon EJ, Landon C, et al. Thresholds for thermal damage to normal tissues: an update. Int J Hyperthermia. 2011;27:320–343.
  • Li GC, Mivechi NF, Weitzel G. Heat shock proteins, thermotolerance, and their relevance to clinical hyperthermia. I J Hyperthermia. 1995;11:459–488.
  • Borrelli MJ, Thompson LL, Cain CA, et al. Time-temperature analysis of cell killing of BHK cells heated at temperatures in the range of 43.5 C to 57.0 C. Int J Rad Oncol* Biol* Phys. 1990;19: 389–399.
  • Field SB, Morris CC. The relationship between heating time and temperature: its relevance to clinical hyperthermia. Radiother Oncol. 1983;1:179–186.
  • Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol. 1995;146:3–15.
  • Vykhodtseva N, Mcdannold N, Martin H, et al. Apoptosis in ultrasound-produced threshold lesions in the rabbit brain. Ultrasound Med Biol. 2001;27:111–117.
  • Wall MS, Deng X, Torzilli PA, et al. Thermal modification of collagen. J Shoulder Elbow Surg. 1999;8: 339–344.
  • Wright NT, Humphrey JD. Denaturation of collagen via heating: an irreversible rate process. Annu Rev Biomed Eng. 2002;4:109–128.
  • Tay KJ, Amin MB, Ghai S, et al. Surveillance after prostate focal therapy. World J Urol. 2019;37:397–407.